Provided by Tiger Trade Technology Pte. Ltd.

Beyond Air, Inc.

0.5440
+0.098822.19%
Post-market: 0.5282-0.0158-2.90%19:59 EDT
Volume:1.75M
Turnover:911.90K
Market Cap:5.73M
PE:-0.11
High:0.5576
Open:0.4948
Low:0.4726
Close:0.4452
52wk High:5.84
52wk Low:0.4300
Shares:10.53M
Float Shares:9.16M
Volume Ratio:2.25
T/O Rate:19.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0645
EPS(LYR):-13.7727
ROE:-240.21%
ROA:-51.20%
PB:0.71
PE(LYR):-0.04

Loading ...

Beyond Air executives to attend D. Boral Capital Global Conference 2026

Reuters
·
Apr 15

Beyond Air to Participate in the D. Boral Capital Global Conference 2026

GlobeNewswire
·
Apr 15

Beyond Air faces Nasdaq delisting after shares trade below $1 bid price

Reuters
·
Apr 11

Beyond Air CEO Steve Lisi resigns; CCO Robert Goodman named CEO

Reuters
·
Apr 02

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences

Reuters
·
Apr 02

Beyond Air Expands Commercial Access for Lungfit® Ph Through a Purchasing Agreement With a Top 3 National Group Purchasing Organization (Gpo)

THOMSON REUTERS
·
Apr 01

Beyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO)

GlobeNewswire
·
Apr 01

Beyond Air Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 27

BTIG Sticks to Its Hold Rating for Beyond Air (XAIR)

TIPRANKS
·
Mar 27

Beyond Air CEO Steve Lisi resigns, Robert Goodman succeeds

TIPRANKS
·
Mar 27

Press Release: Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO

Dow Jones
·
Mar 27

Beyond Air Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 18

Beyond Air Unit Reports Positive Safety Data From Phase 1 Intratumoral Nitric Oxide Monotherapy

MT Newswires Live
·
Mar 18

Beyond Air subsidiary reports signs of clinical activity from UNO trial

TIPRANKS
·
Mar 18

Beyond Cancer reports early clinical activity in Phase 1 UNO solid tumor trial

Reuters
·
Mar 18

Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile With Interim Data From Phase 1 Uno Trial

THOMSON REUTERS
·
Mar 18

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zevra Therapeutics (ZVRA), Verrica Pharmaceuticals (VRCA) and Beyond Air (XAIR)

TIPRANKS
·
Mar 12

Beyond Air CEO Steve Lisi to speak at Roth Conference fireside chat

Reuters
·
Mar 11

Beyond Air to Participate in the 38th Annual Roth Conference in March

GlobeNewswire
·
Mar 11

Beyond Air Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 10